Drug intelligence / Profile preview

BAHCS1

Development stage
Preclinical
Lead developer
U.S. Food & Drug Administration
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

BAHCS1 (Babesia alpha-helical cell surface 1, also known as BmSA1) is a GPI-anchored protein expressed on the surface of *Babesia microti* merozoites and in the cytoplasm of infected erythrocytes. It is being investigated as a recombinant protein subunit vaccine candidate for the prevention of human babesiosis, a tick-borne zoonosis caused by the intraerythrocytic parasite *Babesia microti*. In preclinical studies, immunization with recombinant BAHCS1 (expressed in *E. coli* or mammalian cells) formulated with adjuvants such as Montanide ISA 51/CpG has been shown to induce strong humoral and cellular immune responses, leading to a significant reduction in peak parasitemia and overall parasite burden following challenge.

Other names
Babesia alpha-helical cell surface 1Babesia microti alpha helical cell surface protein 1Babesia microti surface antigen 1

Beyond the preview

Go deeper on BAHCS1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAHCS1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call